glp-1 遠隔 全球首个】GLP-1R/GIPR/GCGR三激动剂项目启动Ⅲ期临床| ACROBiosystems百普赛斯生物科技股份有限公司 🎙️EP163｜GLP-1受體促效劑，瘦瘦針的多重效益與未來展望- Podcast on Firstory
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide (Ozempic/Wegovy) and liraglutide (Victoza/Saxenda) were built for diabetes and obesitybut theyre increasingly being studied for brain health and systemic inflammation.
Learn about GLP-1 agonists, a medical treatment for obesity that mimics a natural hormone to aid weight management
The agency says it is actively monitoring the marketplace and continues to take action against the sale and advertising of unauthorized GLP-1 products, including seizures and the issuance of compliance or warning letters
Explore obesity trends, diabetes treatment innovation, oral GLP-1 drugs, market forecasts, leading companies, and future opportunities through 2035.
Senior Litigation Counsel Jason Goldstein of Parker Waichman LLP appointed Co-Chair of the Plaintiffs Executive Committee in MDL 3163.
GLP-1 medications are showing promising results for endometriosis pain and inflammation
